{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T17:31:25Z","timestamp":1783704685387,"version":"3.55.0"},"reference-count":27,"publisher":"BMJ","issue":"9","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2025,9,10]]},"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:p>Serotonin syndrome is a life-threatening condition characterized by neuromuscular hyperactivity, autonomic dysregulation and altered mental status. Polypharmacy in older adults with multiple comorbidities is associated with increased risk of serotonin syndrome. We report a woman in her 50s with diabetes, hypertension and chronic kidney disease recently misdiagnosed with Parkinsonism. She presented with confusion, hyperreflexia, myoclonus and autonomic instability. Her medications included supratherapeutic paroxetine (40mg two times per day), aripiprazole and benztropine. Symptoms improved with cyproheptadine and cessation of serotonergic agents. However, persistent motor findings prompted further evaluation. Cervical spine MRI showed C4\u2013C5 disc protrusion with ventral cord compression, while brain imaging revealed cerebral atrophy. Cautious administration of haloperidol did not worsen symptoms, suggesting drug-induced or structural Parkinsonism. This case highlights the risk of uncoordinated pharmacotherapy and premature diagnostic closure. The presentation of serotonin syndrome may obscure underlying neurologic pathology, making thorough medication review and multidisciplinary evaluation essential in complex geriatric presentations.<\/jats:p>","DOI":"10.1136\/bcr-2025-267753","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T10:30:35Z","timestamp":1758796235000},"page":"e267753","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Polypharmacy-induced serotonin syndrome revealing underlying neurocognitive impairment and cervical myelopathy"],"prefix":"10.1136","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-3088-7543","authenticated-orcid":false,"given":"Jainam","family":"Shah","sequence":"first","affiliation":[{"name":"Albert Einstein College of Medicine, Bronx, New York, USA"},{"name":"Department of Psychiatry and Behavioral Sciences, Montefiore Medical Center, Bronx, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Parsons","sequence":"additional","affiliation":[{"name":"Albert Einstein College of Medicine, Bronx, New York, USA"},{"name":"Department of Psychiatry and Behavioral Sciences, Montefiore Medical Center, Bronx, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin","family":"Pathuri","sequence":"additional","affiliation":[{"name":"Albert Einstein College of Medicine, Bronx, New York, USA"},{"name":"Department of Psychiatry and Behavioral Sciences, Montefiore Medical Center, Bronx, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Lieberman","sequence":"additional","affiliation":[{"name":"Albert Einstein College of Medicine, Bronx, New York, USA"},{"name":"Department of Psychiatry and Behavioral Sciences, Montefiore Medical Center, Bronx, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candace","family":"Hatten-Powell","sequence":"additional","affiliation":[{"name":"Albert Einstein College of Medicine, Bronx, New York, USA"},{"name":"Department of Psychiatry and Behavioral Sciences, Montefiore Medical Center, Bronx, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,9,25]]},"reference":[{"key":"2025092503301694000_18.9.e267753.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra041867"},{"key":"2025092503301694000_18.9.e267753.2","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/psyg.12849","article-title":"Antidepressant-induced serotonin syndrome in older patients: a cross-sectional study","volume":"22","author":"Erken","year":"2022","journal-title":"Psychogeriatrics"},{"key":"2025092503301694000_18.9.e267753.3","doi-asserted-by":"crossref","first-page":"e300","DOI":"10.1097\/MJT.0000000000001685","article-title":"Serotonin Syndrome From the Complex Drug Interactions of Second-Generation Antipsychotics in Older Patients: Case Report and Literature Review","volume":"31","author":"Hsieh","year":"2024","journal-title":"Am J Ther"},{"key":"2025092503301694000_18.9.e267753.4","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.148.6.705"},{"key":"2025092503301694000_18.9.e267753.5","doi-asserted-by":"publisher","DOI":"10.1177\/026988119901300111"},{"key":"2025092503301694000_18.9.e267753.6","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/88.4.603"},{"key":"2025092503301694000_18.9.e267753.7","doi-asserted-by":"crossref","DOI":"10.1177\/1178646919873925","article-title":"Serotonin Syndrome: Pathophysiology, Clinical Features, Management, and Potential Future Directions","volume":"12","author":"Scotton","year":"2019","journal-title":"Int J Tryptophan Res"},{"key":"2025092503301694000_18.9.e267753.8","unstructured":"Simon LV , Torrico TJ , Keenaghan M . Serotonin syndrome. In: StatPearls. Treasure Island (FL): StatPearls Publishing, 2025. Available: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK482377\/"},{"key":"2025092503301694000_18.9.e267753.9","doi-asserted-by":"publisher","DOI":"10.1054\/mehy.2000.1047"},{"key":"2025092503301694000_18.9.e267753.10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4103\/ajm.AJM_7_19","article-title":"Focal seizure as a manifestation of serotonin syndrome: case report","volume":"9","author":"Almallouhi","year":"2019","journal-title":"Avicenna J Med"},{"key":"2025092503301694000_18.9.e267753.11","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1177\/1751143715626732","article-title":"The role of electroencephalography in the diagnosis of serotonin syndrome","volume":"17","author":"Krishnamoorthy","year":"2016","journal-title":"J Intensive Care Soc"},{"key":"2025092503301694000_18.9.e267753.12","doi-asserted-by":"crossref","DOI":"10.12659\/AJCR.938268","article-title":"A 70-Year-Old Woman Presenting with Confusion and Muscle Spasms Due to Serotonin Syndrome Associated with Paroxetine and Quetiapine Treatment","volume":"23","author":"Mostel","year":"2022","journal-title":"Am J Case Rep"},{"key":"2025092503301694000_18.9.e267753.13","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2014-204154","article-title":"Serotonin syndrome versus neuroleptic malignant syndrome: a challenging clinical quandary","volume":"2014","author":"Dosi","year":"2014","journal-title":"BMJ Case Rep"},{"key":"2025092503301694000_18.9.e267753.14","doi-asserted-by":"crossref","first-page":"S565","DOI":"10.1192\/j.eurpsy.2024.1175","article-title":"Serotonin Syndrome Following Low-Dose Sertraline: A Case Report","volume":"67","author":"Chan","year":"2024","journal-title":"Eur Psychiatr"},{"key":"2025092503301694000_18.9.e267753.15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)78999-6"},{"key":"2025092503301694000_18.9.e267753.16","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-015-0128-z","article-title":"Comprehensive treatment of dementia with Lewy bodies","volume":"7","author":"Boot","year":"2015","journal-title":"Alzheimers Res Ther"},{"key":"2025092503301694000_18.9.e267753.17","doi-asserted-by":"publisher","DOI":"10.1097\/01.wnf.0000177642.89888.85"},{"key":"2025092503301694000_18.9.e267753.18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00228-011-1094-4","article-title":"The relationship between clinical pharmacokinetics of aripiprazole and CYP2D6 genetic polymorphism: effects of CYP enzyme inhibition by coadministration of paroxetine or fluvoxamine","volume":"68","author":"Azuma","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"key":"2025092503301694000_18.9.e267753.19","doi-asserted-by":"publisher","DOI":"10.1177\/2045125314561467"},{"key":"2025092503301694000_18.9.e267753.20","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/bcp.16152","article-title":"Management of serotonin syndrome (toxicity)","volume":"91","author":"Chiew","year":"2025","journal-title":"Brit J Clinical Pharma"},{"key":"2025092503301694000_18.9.e267753.21","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1111\/medu.13382","article-title":"Avoiding premature closure and reaching diagnostic accuracy: some key predictive factors","volume":"51","author":"Krupat","year":"2017","journal-title":"Med Educ"},{"key":"2025092503301694000_18.9.e267753.22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1303712"},{"key":"2025092503301694000_18.9.e267753.23","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1515\/dx-2022-0013","article-title":"Pursuit of \u201cendpoint diagnoses\u201d as a cognitive forcing strategy to avoid premature diagnostic closure","volume":"9","author":"Kaplan","year":"2022","journal-title":"Diagnosis (Berl)"},{"key":"2025092503301694000_18.9.e267753.24","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2012.2246"},{"key":"2025092503301694000_18.9.e267753.25","unstructured":"Research C for DE and Drug Development and Drug Interactions . Table of substrates, inhibitors and inducers. FDA; 2024. Available: https:\/\/www.fda.gov\/drugs\/drug-interactions-labeling\/drug-development-and-drug-interactions-table-substrates-inhibitors-and-inducers"},{"key":"2025092503301694000_18.9.e267753.26","unstructured":"DailyMed. 2025 Available: https:\/\/dailymed.nlm.nih.gov\/dailymed\/"},{"key":"2025092503301694000_18.9.e267753.27","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/jgs.15767","article-title":"American Geriatrics Society 2019 Updated AGS Beers Criteria\u00ae for Potentially Inappropriate Medication Use in Older Adults","volume":"67","year":"2019","journal-title":"J American Geriatrics Society"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2025-267753","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T10:30:41Z","timestamp":1758796241000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2025-267753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":27,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9,25]]},"published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10.1136\/bcr-2025-267753"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2025-267753","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]}}}